Variable | Univariate analysis | Multivariate analysisc | ||||
---|---|---|---|---|---|---|
HRa | 95% CIb | P | HR | 95% CI | P | |
Overall survival (n = 522) | ||||||
CENPA | ||||||
Low (n = 261) | 2.384 | 1.722–3.3 | 0.003 | 1.656 | 1.17–2.344 | 0.004 |
High (n = 261) | ||||||
Age | ||||||
< 60 (n = 235) | 1.641 | 1.196–2.252 | 0.002 | 1.391 | 1.003–1.928 | 0.048 |
≥ 60 (n = 287) | ||||||
Gender | ||||||
Female (n = 183) | 1.071 | 0.783–1.464 | 0.669 | 1.239 | 0.894–1.717 | 0.198 |
Male (n = 339) | ||||||
T stage | ||||||
T1 or T2 (n = 336) | 3.184 | 2.336–4.329 | < 0.001 | 1.626 | 1.127–2.347 | 0.009 |
T3 or T4 (n = 186) | ||||||
N stage | ||||||
N0 or NX (n = 507) | 3.96 | 2.143–7.315 | < 0.001 | 2.087 | 1.101–3.956 | 0.024 |
N1 (n = 15) | ||||||
M stage | ||||||
M0 or MX (n = 445) | 4.378 | 3.199–5.992 | < 0.001 | 2.52 | 1.752–3.625 | < 0.001 |
M1 (n = 77) | ||||||
G grade | ||||||
Gx or G1 or G2 (n = 245) | 2.681 | 1.901–3.782 | < 0.001 | 1.638 | 1.129–2.377 | 0.009 |
G3 or G4 (n = 277) |